| Dr Michael E Willers, MD | |
|
1754 Northampton Street, Holyoke, MA 01040 | |
| (413) 315-3117 | |
| (866) 229-2767 |
| Full Name | Dr Michael E Willers |
|---|---|
| Gender | Male |
| Speciality | Cardiovascular Disease (cardiology) |
| Experience | 25 Years |
| Location | 1754 Northampton Street, Holyoke, Massachusetts |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1518087790 | NPI | - | NPPES |
| 008030403 | Medicaid | CT | |
| 110080495A | Medicaid | MA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208000000X | Pediatrics | 237999 (Massachusetts) | Secondary |
| 2080P0202X | Pediatrics - Pediatric Cardiology | 237999 (Massachusetts) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Massachusetts General Physicians Organization Inc | 2466365820 | 3085 |
News Archive
CONNECT(R), one of the nation's most successful organizations dedicated to creating and sustaining the growth of innovative technology and life science businesses, announced SynergEyes, Inc., the high Dk hybrid contact lens manufacturer, as the winner of its 22nd annual Most Innovative New Product (MIP) Award for 2009.
New research by scientists at Cedars-Sinai's Maxine Dunitz Neurosurgical Institute suggests that a drug currently approved to treat erectile dysfunction may significantly enhance the delivery of the anti-cancer drug Herceptin to certain hard-to-treat brain tumors.
Scientists at Indiana University found high levels of a previously unsuspected pollutant in homes, in an electronic waste recycling facility and in the natural environment. People are likely to be exposed to this pollutant by breathing contaminated dust or through skin contact.
When prostate cancer spreads it is often a deadly disease, but now a Stony Brook University-led research team believes a new approach that inhibits a specific fatty acid binding protein (FABP) may be the key to halting disease progression.
› Verified 8 days ago
| Entity Name | Massachusetts General Physicians Organization Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1801874573 PECOS PAC ID: 2466365820 Enrollment ID: O20031111000434 |
News Archive
CONNECT(R), one of the nation's most successful organizations dedicated to creating and sustaining the growth of innovative technology and life science businesses, announced SynergEyes, Inc., the high Dk hybrid contact lens manufacturer, as the winner of its 22nd annual Most Innovative New Product (MIP) Award for 2009.
New research by scientists at Cedars-Sinai's Maxine Dunitz Neurosurgical Institute suggests that a drug currently approved to treat erectile dysfunction may significantly enhance the delivery of the anti-cancer drug Herceptin to certain hard-to-treat brain tumors.
Scientists at Indiana University found high levels of a previously unsuspected pollutant in homes, in an electronic waste recycling facility and in the natural environment. People are likely to be exposed to this pollutant by breathing contaminated dust or through skin contact.
When prostate cancer spreads it is often a deadly disease, but now a Stony Brook University-led research team believes a new approach that inhibits a specific fatty acid binding protein (FABP) may be the key to halting disease progression.
› Verified 8 days ago
| Entity Name | Baystate Medical Practices Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1548205909 PECOS PAC ID: 5991602971 Enrollment ID: O20040225000080 |
News Archive
CONNECT(R), one of the nation's most successful organizations dedicated to creating and sustaining the growth of innovative technology and life science businesses, announced SynergEyes, Inc., the high Dk hybrid contact lens manufacturer, as the winner of its 22nd annual Most Innovative New Product (MIP) Award for 2009.
New research by scientists at Cedars-Sinai's Maxine Dunitz Neurosurgical Institute suggests that a drug currently approved to treat erectile dysfunction may significantly enhance the delivery of the anti-cancer drug Herceptin to certain hard-to-treat brain tumors.
Scientists at Indiana University found high levels of a previously unsuspected pollutant in homes, in an electronic waste recycling facility and in the natural environment. People are likely to be exposed to this pollutant by breathing contaminated dust or through skin contact.
When prostate cancer spreads it is often a deadly disease, but now a Stony Brook University-led research team believes a new approach that inhibits a specific fatty acid binding protein (FABP) may be the key to halting disease progression.
› Verified 8 days ago
| Entity Name | The General Hospital Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1023049236 PECOS PAC ID: 6507803806 Enrollment ID: O20080313000351 |
News Archive
CONNECT(R), one of the nation's most successful organizations dedicated to creating and sustaining the growth of innovative technology and life science businesses, announced SynergEyes, Inc., the high Dk hybrid contact lens manufacturer, as the winner of its 22nd annual Most Innovative New Product (MIP) Award for 2009.
New research by scientists at Cedars-Sinai's Maxine Dunitz Neurosurgical Institute suggests that a drug currently approved to treat erectile dysfunction may significantly enhance the delivery of the anti-cancer drug Herceptin to certain hard-to-treat brain tumors.
Scientists at Indiana University found high levels of a previously unsuspected pollutant in homes, in an electronic waste recycling facility and in the natural environment. People are likely to be exposed to this pollutant by breathing contaminated dust or through skin contact.
When prostate cancer spreads it is often a deadly disease, but now a Stony Brook University-led research team believes a new approach that inhibits a specific fatty acid binding protein (FABP) may be the key to halting disease progression.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Michael E Willers, MD 1754 Northampton Street, Holyoke, MA 01040 Ph: (413) 315-3117 | Dr Michael E Willers, MD 1754 Northampton Street, Holyoke, MA 01040 Ph: (413) 315-3117 |
News Archive
CONNECT(R), one of the nation's most successful organizations dedicated to creating and sustaining the growth of innovative technology and life science businesses, announced SynergEyes, Inc., the high Dk hybrid contact lens manufacturer, as the winner of its 22nd annual Most Innovative New Product (MIP) Award for 2009.
New research by scientists at Cedars-Sinai's Maxine Dunitz Neurosurgical Institute suggests that a drug currently approved to treat erectile dysfunction may significantly enhance the delivery of the anti-cancer drug Herceptin to certain hard-to-treat brain tumors.
Scientists at Indiana University found high levels of a previously unsuspected pollutant in homes, in an electronic waste recycling facility and in the natural environment. People are likely to be exposed to this pollutant by breathing contaminated dust or through skin contact.
When prostate cancer spreads it is often a deadly disease, but now a Stony Brook University-led research team believes a new approach that inhibits a specific fatty acid binding protein (FABP) may be the key to halting disease progression.
› Verified 8 days ago
David N Gottsegen, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 150 Lower Westfield Rd, Ste1, Holyoke, MA 01040 Phone: 413-536-2393 Fax: 413-536-1087 | |
Dr. Jacqueline L. Pleet, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 150 Lower Westfield Rd, Ste1, Holyoke, MA 01040 Phone: 413-536-2393 Fax: 413-536-1087 | |
David L Bogan, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 150 Lower Westfield Rd, Ste1, Holyoke, MA 01040 Phone: 413-536-2393 Fax: 413-536-1087 | |
Robert M Abrams, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 150 Lower Westfield Rd, Ste1, Holyoke, MA 01040 Phone: 413-536-2393 Fax: 413-536-1087 | |
Jacqueline Spain, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 230 Maple St, Holyoke, MA 01040 Phone: 413-420-2200 Fax: 413-420-2260 | |
Victoria L. Pillard, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 150 Lower Westfield Rd, Ste1, Holyoke, MA 01040 Phone: 413-536-2393 Fax: 413-536-1087 | |
Erica H Kates, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 150 Lower Westfield Rd Ste 1, Holyoke, MA 01040 Phone: 413-536-2393 Fax: 413-536-1087 |